These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines. Hampl M. Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854 [Abstract] [Full Text] [Related]
3. Human papillomavirus, cervical cancer, and the vaccines. Tovar JM, Bazaldua OV, Vargas L, Reile E. Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072 [Abstract] [Full Text] [Related]
5. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Paavonen J. Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244 [Abstract] [Full Text] [Related]
7. Cervical cancer prevention in the human papilloma virus vaccine era. Ghazal-Aswad S. Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904 [Abstract] [Full Text] [Related]
9. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention]. Kohl I. Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469 [Abstract] [Full Text] [Related]
10. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M, Dillner J. J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503 [Abstract] [Full Text] [Related]
11. Advantages and disadvantages of current prophylactic vaccines against HPV. Madrid-Marina V, Torres-Poveda K, López-Toledo G, García-Carrancá A. Arch Med Res; 2009 Aug; 40(6):471-7. PubMed ID: 19853187 [Abstract] [Full Text] [Related]
15. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland. Syrjänen KJ. Scand J Infect Dis Suppl; 2009 May; 107():3-32. PubMed ID: 19408160 [Abstract] [Full Text] [Related]
16. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A. Vaccine; 2010 Nov 29; 28(51):8065-72. PubMed ID: 20971114 [Abstract] [Full Text] [Related]
18. [Human papillomavirus vaccination. Consensus Conference in pediatric age]. Bartolozzi G, Bona G, Ciofi M, De Martino M, Di Pietro P, Duse M, Esposito S, Gasparini R, Mariani L, Marostica G, Paravati F, Plebani A, Principi N, Zuccotti GV, Tovo PA. Minerva Pediatr; 2007 Jun 29; 59(3):165-82. PubMed ID: 17519861 [Abstract] [Full Text] [Related]
19. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control]. Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H. Bull Acad Natl Med; 2007 Dec 29; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976 [Abstract] [Full Text] [Related]
20. The epidemiology behind the HPV vaccine discovery. Koutsky L. Ann Epidemiol; 2009 Apr 29; 19(4):239-44. PubMed ID: 19344861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]